Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck (Q43602917)

25 November 2017

title

Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck (English)

1 reference

adaptive radiation therapy

25 November 2017

main subject

0 references

1 reference

25 November 2017

John A Vargo

1 reference

25 November 2017

Rodney E Wegner

1 reference

25 November 2017

Dwight E Heron

1 reference

25 November 2017

Jean-Claude M Rwigema

1 reference

25 November 2017

Annette Quinn

1 reference

25 November 2017

Patricia Gigliotti

1 reference

25 November 2017

James Ohr

1 reference

25 November 2017

Greg J Kubicek

1 reference

25 November 2017

Steven Burton

1 reference

25 November 2017

publication date

11 November 2011

1 reference

25 November 2017

1 reference

25 November 2017

1 reference

25 November 2017

1 reference

25 November 2017

page(s)

1153-1161

1 reference

Head and neck cancer: changing epidemiology, diagnosis, and treatment

25 November 2017

cites work

1 reference

Head and neck tumors other than squamous cell carcinoma.

21 January 2018

1 reference

Salivary gland carcinomas, paranasal sinus cancers and melanoma of the head and neck: an update about rare but challenging tumors

21 January 2018

1 reference

Distant metastasis in adenoid cystic carcinoma of salivary origin

21 January 2018

1 reference

Adenoid cystic carcinoma of the salivary glands. Management of recurrent, advanced, or persistent disease with hyperthermia and radiation therapy.

21 January 2018

1 reference

Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas

21 January 2018

1 reference

Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?

21 January 2018

1 reference

The role of stereotactic radiosurgery in the treatment of malignant skull base tumors

21 January 2018

1 reference

Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: Efficacy and complications

21 January 2018

1 reference

Image-guided radiosurgery of head and neck cancers

21 January 2018

1 reference

Frameless stereotactic radiosurgery for recurrent head and neck carcinoma

21 January 2018

1 reference

Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region

21 January 2018

1 reference

Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma

21 January 2018

1 reference

Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R).

21 January 2018

1 reference

Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.

21 January 2018

1 reference

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer

21 January 2018

1 reference

Surgical salvage after chemoradiation of head and neck cancer: complications and outcomes

21 January 2018

1 reference

RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck

21 January 2018

1 reference

Chemoreirradiation for recurrent salivary gland malignancies

21 January 2018

1 reference

Salivary gland malignancies: the role for chemotherapy and molecular targeted agents

21 January 2018

1 reference

Adenoid cystic salivary gland carcinoma. A histopathologic review of treatment failure patterns

21 January 2018

1 reference

Induction chemotherapy with cisplatin and gemcitabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma

21 January 2018

1 reference

Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype

21 January 2018

1 reference

7 January 2021

Radiosurgery for recurrent cranial base cancer arising from the head and neck

1 reference

7 January 2021

Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma

1 reference

7 January 2021

Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer

1 reference

7 January 2021

Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer

1 reference

7 January 2021

Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers

1 reference

7 January 2021

Response evaluation criteria in solid tumors (RECIST): new guidelines

1 reference

7 January 2021

Stereotactic Body Radiation Therapy for Head and Neck Tumor: Disease Control and Morbidity Outcomes

1 reference

7 January 2021

Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study

1 reference

7 January 2021

Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911

1 reference

7 January 2021

Emerging applications of stereotactic radiotherapy in head and neck cancer

1 reference

7 January 2021

Treatment of salivary gland neoplasms with fast neutron radiotherapy

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21889

1 reference

25 November 2017

1 reference